Voluntary Scheme for Branded Medicines Pricing and Access: Life Sciences

(asked on 24th January 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with the Secretary of State for Business, Energy, and Industrial Strategy on the impact of the Voluntary Scheme for Branded Medicines Pricing Access on the life sciences sector.


Answered by
Will Quince Portrait
Will Quince
This question was answered on 30th January 2023

Ministers in the Department engage regularly with their Ministerial counterparts on a range of issues, including those relating to the Voluntary Scheme for Branded Medicines Pricing Access.

Reticulating Splines